We are live on ! Find out more
PSTV icon

Plus Therapeutics

11 hedge funds and large institutions have $875K invested in Plus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more funds holding

Funds holding: 511 (+6)

59% more capital invested

Capital invested by funds: $552K → $875K (+$323K)

0% more ownership

Funds ownership: 0.02%0.02% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
11
Holders Change
+6
Holders Change %
+120%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$310K
Goldman Sachs
2
Goldman Sachs
New York
$166K +$168K +173 New
Renaissance Technologies
3
Renaissance Technologies
New York
$90K -$127K -131 -58%
Bank of New York Mellon
4
Bank of New York Mellon
New York
$79K
Citadel Advisors
5
Citadel Advisors
Florida
$58K +$58.2K +60 New
VF
6
Virtu Financial
New York
$56K +$56.2K +58 New
Two Sigma Investments
7
Two Sigma Investments
New York
$42K +$42.7K +44 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$39K
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$23K
Osaic Holdings
10
Osaic Holdings
Arizona
$9K +$8.73K +9 New
TRCT
11
Tower Research Capital (TRC)
New York
$3K +$2.91K +3 New
FP
12
Financial Perspectives
Minnesota
$3